Phibro Animal Health Corporation Reports Third Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Guggenheim Cuts Price Target on Phibro Animal Health (PAHC) Following 3Q Miss
May 10, 2016 2:06 PM EDTGuggenheim maintained a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and cut the price target to $26.00 (from $34.00), following the company's 3Q earnings report. PAHC reported F'3Q16 EPS of $0.38, $0.03 lower than consensus. PAHC lowered its F'16 revenue and EPS guidance to $745MM-$750MM, and... More
Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
May 9, 2016 4:19 PM EDTPhibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.38, $0.05 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $183 million versus the consensus estimate of $197.24 million.
GUIDANCE:
Phibro Animal Health sees FY2016 EPS of $1.58-$1.60, versus the... More
